Literature DB >> 11246814

Role of adipose tissue for cardiovascular-renal regulation in health and disease.

S Engeli1, A M Sharma.   

Abstract

Obesity is associated with profound alterations of the cardiovascular system including an increase in systemic blood pressure. Several vasoactive factors, including non-esterified fatty acids, angiotensin II, prostaglandins, and nitric oxide are known to be produced by adipose tissue, and are therefore of particular interest regarding their potential role for the regulation of vascular tone and structure. In addition, central nervous system actions of the adipose tissue-derived hormone leptin may contribute to increased sympathetic nervous system activity that is typically found in obesity. Enhanced leptin-driven renal sympathetic out-flow, in combination with low atrial natriuretic peptide plasma levels possibly due to over-expression of the natriuretic peptide clearance receptor in adipocytes, may enhance sodium retention and volume expansion, both key features in the pathophysiology of obesity-associated hypertension. In this review, we discuss these and other possible contributions of adipose tissue to the regulation of cardiovascular-renal function and speculate on the role of adipose tissue for the development of obesity-associated hypertension.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11246814     DOI: 10.1055/s-2007-978675

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  10 in total

1.  Leptin responses to short term exercise in college level male rowers.

Authors:  J Jürimäe; T Jürimäe
Journal:  Br J Sports Med       Date:  2005-01       Impact factor: 13.800

2.  Linkage of angiotensinogen gene polymorphisms with hypertension in a sibling study of Hong Kong Chinese.

Authors:  Yu-Jing Fang; Han-Bing Deng; G Neil Thomas; Chi H Tzang; Cai-Xia Li; Zong-Li Xu; Mengsu Yang; Brian Tomlinson
Journal:  J Hypertens       Date:  2010-06       Impact factor: 4.844

Review 3.  Adipose tissue-mediated inflammation: the missing link between obesity and cardiovascular disease?

Authors:  Paolo Calabrò; Enrica Golia; Valeria Maddaloni; Marco Malvezzi; Beniamino Casillo; Carla Marotta; Raffaele Calabrò; Paolo Golino
Journal:  Intern Emerg Med       Date:  2008-12-04       Impact factor: 3.397

Review 4.  Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review.

Authors:  John N Fain
Journal:  Mediators Inflamm       Date:  2010-05-23       Impact factor: 4.711

Review 5.  Insulin resistance and the sympathetic nervous system.

Authors:  Brent M Egan
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

6.  Dissociation between sympathetic nerve traffic and sympathetically mediated vascular tone in normotensive human obesity.

Authors:  Alexei Vasilievich Agapitov; Marcelo Lima de Gusmão Correia; Christine Ann Sinkey; William Geoffrey Haynes
Journal:  Hypertension       Date:  2008-08-11       Impact factor: 10.190

Review 7.  Insulin and its role in chronic kidney disease.

Authors:  Robert H Mak
Journal:  Pediatr Nephrol       Date:  2007-10-11       Impact factor: 3.714

Review 8.  Obesity, hypertension and aldosterone: is leptin the link?

Authors:  Ding Xie; Wendy B Bollag
Journal:  J Endocrinol       Date:  2016-06-01       Impact factor: 4.286

9.  A body shape index and heart rate variability in healthy indians with low body mass index.

Authors:  Sharma Sowmya; Tinku Thomas; Ankalmadagu Venkatsubbareddy Bharathi; Sambashivaiah Sucharita
Journal:  J Nutr Metab       Date:  2014-10-02

Review 10.  Does inflammation determine whether obesity is metabolically healthy or unhealthy? The aging perspective.

Authors:  Iftikhar Alam; Tze Pin Ng; Anis Larbi
Journal:  Mediators Inflamm       Date:  2012-10-04       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.